Does Vyvanse cause acne? Acne is not listed as a standard side effect in Vyvanse’s official prescribing information, but real-world pharmacovigilance data, patient reports, and the pharmacological evidence on Vyvanse’s hormonal and physiological effects make clear it can occur in a meaningful subset of users. Phase IV clinical study data from the FDA’s eHealthMe database identifies acne as a reported adverse effect among Vyvanse users. The most clinically credible mechanism is Vyvanse’s stimulation of the hypothalamic-pituitary-adrenal (HPA) axis — specifically its documented elevation of adrenal androgens including DHEA, DHEA-S, and androstenedione — which increases sebum production and creates the hormonal environment in which acne thrives. This is not a universal effect, but for susceptible patients — particularly adult women — it is a real and sometimes severe one.
What the Science Says: The Hormonal Evidence
The key piece of pharmacological evidence here is both specific and often absent from online discussions about Vyvanse and acne:
A controlled pharmacology study examining lisdexamfetamine’s hormonal effects found that the medication stimulates the hypothalamic-pituitary-adrenal (HPA) axis — increasing cortisol, ACTH, and critically, adrenal androgens: DHEA, DHEA-S, and androstenedione. The same study confirmed it does not significantly alter testosterone or gonadal hormone production. This distinction is clinically important.
The significance for acne: DHEA (dehydroepiandrosterone) and androstenedione are precursor androgens that are converted — particularly in skin tissue itself — to the more potent androgens testosterone and DHT. DHT is the primary androgen driving sebaceous gland activity and sebum production. An elevation of adrenal androgen precursors therefore produces a downstream increase in sebum output from the sebaceous glands — the biological substrate for acne.
A 1991 study published in PubMed examining women with postadolescent acne confirmed this mechanism: women with acne had significantly higher basal and ACTH-stimulated DHEA concentrations compared to acne-free controls, with a significantly elevated DHEA-to-cortisol ratio suggesting adrenal androgen predominance. Vyvanse directly activates the very axis — adrenal DHEA secretion — that this research identifies as the driver of adult female acne.
This is the most mechanistically specific explanation for Vyvanse-associated acne, and it specifically explains why the effect is concentrated in adult women, not adolescent males.
The Four Mechanisms That Explain Vyvanse-Related Acne
Mechanism 1: Adrenal Androgen Elevation → Increased Sebum
As described above — Vyvanse’s HPA axis stimulation elevates DHEA and androstenedione, which are converted to testosterone and DHT in skin tissue, stimulating sebaceous gland cells to produce excess sebum. Excess sebum is the most proximate cause of acne: it fills and dilates follicular canals, creates anaerobic conditions that allow Cutibacterium acnes to proliferate, and triggers the inflammatory response that produces papules, pustules, nodules, and cysts.
One patient’s experience captured this mechanism precisely: “Blood tests revealed that my DHEA level was nearly three times higher than what is typical for a woman in her 30s. After discontinuing Vyvanse within 1–2 weeks, I stopped seeing new breakouts”. This is not anecdotal — it is a patient inadvertently measuring the exact biomarker that the pharmacological evidence predicts should be elevated.
Mechanism 2: Cortisol Elevation → Sebum + Inflammation
Cortisol elevation from Vyvanse’s sympathetic activation independently drives acne through two pathways:
- Increased sebum production — cortisol stimulates sebaceous gland activity directly, compounding the androgen-driven effect
- Skin barrier disruption — elevated cortisol weakens the skin’s barrier function, increasing its susceptibility to bacterial colonisation and inflammatory response
- Inflammatory amplification — cortisol promotes the release of pro-inflammatory cytokines in skin tissue, worsening the severity of breakouts even when sebum volume alone would produce only mild acne
The jawline and chin distribution of Vyvanse-related acne reported consistently in patient communities — “cystic acne along my jawline”, “breakouts occurring in the same spots — my jawline and neckline” — is characteristic of androgen and cortisol-driven hormonal acne, not comedonal or seborrhoeic patterns.
Mechanism 3: Dehydration → Compensatory Oil Production
Vyvanse reduces saliva, suppresses thirst, and increases metabolic rate — a combination that consistently produces mild to moderate dehydration in patients who do not actively compensate:
When the skin becomes dehydrated, it loses water content (distinct from oil content) and the stratum corneum becomes compromised. The sebaceous glands respond by upregulating sebum production to compensate for the disrupted barrier — an ironic overcorrection that produces the oily-skin-despite-dehydration pattern many Vyvanse users describe. The combination of excess sebum from compensatory oil production, dead cell accumulation from a compromised barrier, and reduced skin immunity from dehydration creates ideal conditions for comedone formation and inflammatory acne.
As one patient explained accurately: “Vyvanse is well-known for leading to dehydration in the body, which can prominently affect the skin. This condition can result in an accumulation of dead skin cells and flaking, leading to clogged pores. Additionally, your skin might produce excess oil as it tries to compensate”.
Mechanism 4: Nutritional Deficiency (Especially Zinc)
Vyvanse’s appetite suppression can produce meaningful nutritional deficiencies in patients who regularly skip meals or eat insufficiently:
Zinc deficiency is particularly relevant to acne: zinc plays a direct anti-inflammatory role in the skin, inhibits C. acnes proliferation, and regulates sebaceous gland activity. As one patient in the patient community correctly identified: “Stimulants can deplete vitamins and nutrients, including zinc, which is essential for skin health. Consider taking zinc picolinate or having your zinc levels tested”.
Additional nutritional factors with evidence for skin health relevance include omega-3 fatty acids (anti-inflammatory), vitamin A (regulates sebaceous gland turnover), and B vitamins broadly. All can be depleted by consistent under-eating driven by Vyvanse’s appetite suppression.
Who Is Most Likely to Experience Vyvanse-Related Acne
Patient reports and the pharmacological evidence point to a consistent risk profile:
- Adult women (particularly ages 18–40) — the adrenal androgen pathway is most clinically significant in women, whose skin is more androgen-sensitive in the relevant tissue ranges. Postadolescent hormonal acne is an almost exclusively female clinical entity driven by the exact pathway Vyvanse activates
- Patients on higher doses — higher doses produce greater HPA axis activation, greater cortisol and DHEA elevation, and more pronounced appetite suppression with greater nutritional depletion risk
- Patients with a personal history of hormonal acne — prior sensitivity to the DHEA/androgen axis means the additional load from Vyvanse crosses the clinical threshold more easily
- Patients who are chronically under-hydrated — dehydration’s role in the sebum-overproduction pathway makes this a meaningful risk modifier
- Patients who skip meals regularly due to appetite suppression — nutritional vulnerability, particularly zinc, is most pronounced in this group
- Adolescent patients — already in a state of elevated adrenal androgen activity; the additional DHEA stimulation from Vyvanse compounds an already androgenic environment
The Pattern of Vyvanse-Related Acne: What It Looks Like
The clinical and patient literature describes a consistent phenotype:
- Location: Predominantly jawline, chin, and neck — the anatomical distribution characteristic of androgen-driven hormonal acne, where androgen receptor density in sebaceous glands is highest
- Type: Deep, nodular, or cystic lesions rather than superficial whiteheads or blackheads — consistent with inflammation-driven acne rather than simple comedonal acne
- Body acne: Some patients report concurrent back, chest, and shoulder breakouts, which is consistent with the systemic nature of elevated adrenal androgens and cortisol
- Oiliness: Increased facial oiliness is a consistent accompanying symptom, reflecting the sebum-stimulating mechanism
- Onset: Typically within weeks to months of starting Vyvanse or increasing the dose — reflecting the time needed for hormonal shifts to manifest as visible skin changes
- Dose correlation: Multiple patient reports specifically document acne worsening with dose increases and improving with dose reductions — a dose-response relationship that strongly supports medication causality
The Temporal Evidence: Why Patient Reports Are Credible
The strongest evidence for Vyvanse causing acne is the temporal correlation — clear, consistent, and reproducible patterns that meet basic scientific criteria for probable causality:
- Acne begins or significantly worsens within weeks of starting Vyvanse or increasing the dose
- Acne improves or resolves during medication holidays, gaps in prescription, or dose reductions
- Acne returns when Vyvanse is restarted
These are not isolated experiences. Across multiple forums, patient communities, and pharmacovigilance reports, the same timeline is described with remarkable consistency. As one patient described after 11 days off Vyvanse: “My skin has cleared up almost completely for the first time since May 2023”. Another: “I was on and off Vyvanse this year and consistently noticed horrible cystic acne along my jawline whenever I’m on it”.
The fact that dermatologists often fail to identify Vyvanse as a cause — as multiple patients report being told there is “no clinical link” — reflects a gap between dermatological and psychiatric prescribing knowledge rather than the absence of a real effect. The pharmacological mechanism is established; the clinical recognition has not yet caught up.
What to Do If Vyvanse Is Causing Your Acne
Step 1: Confirm the Temporal Link
Before attributing acne to Vyvanse, establish the timeline:
- Did acne begin or worsen after starting Vyvanse or increasing the dose?
- Does it improve on days or weeks without the medication?
- Is it worse at higher doses?
If yes to at least two of these, medication causality is probable. Take a photograph record and timeline to your prescriber — this is the most persuasive clinical evidence available.
Step 2: Optimise Hydration Immediately
This is the most accessible first intervention and addresses one of the most modifiable mechanisms:
- Aim for 2.5–3 litres of water per day — set timed reminders, as Vyvanse suppresses thirst
- Avoid caffeinated beverages as your primary fluid — they compound Vyvanse-driven dehydration
- Use a hydrating, non-comedogenic moisturiser twice daily — dehydrated skin needs topical water content restoration alongside systemic hydration
- Consider adding a hyaluronic acid serum — it draws water into the skin surface and significantly reduces the compensatory oil production cycle
Step 3: Address Nutritional Gaps
- Have your GP test zinc, ferritin, vitamin D, and vitamin A levels
- Consider zinc supplementation (zinc picolinate 15–30 mg/day with food) — zinc has one of the strongest evidence bases for acne management of any supplement, and Vyvanse-driven dietary restriction makes deficiency particularly common
- Eat regular, structured meals to maintain adequate micronutrient intake — use scheduled meal times rather than appetite as the cue
- Prioritise anti-inflammatory foods: omega-3-rich foods (oily fish, flaxseed), colourful vegetables, and low-glycaemic-index carbohydrates (high-GI diets independently worsen hormonal acne)
Step 4: Adjust Skincare for Stimulant-Related Acne
The dehydrated-but-oily pattern of Vyvanse acne requires a specific approach:
- Gentle, non-stripping cleanser — harsh cleansers worsen the barrier disruption that drives compensatory oil production
- Non-comedogenic moisturiser with SPF — morning and evening; do not skip moisturiser because skin feels oily
- Salicylic acid (BHA) — 2% in a leave-on serum or toner; penetrates pores and dissolves sebum without over-drying
- Niacinamide (vitamin B3) 5–10% — reduces sebum production, minimises pores, reduces inflammation, and strengthens the skin barrier — specifically relevant to the dehydration-sebum cycle
- Do not pick or manipulate cystic lesions — deep nodular lesions from hormonal acne scar easily and picking significantly worsens both scarring and bacterial spread
Step 5: Speak to Both Your Prescriber and Your Dermatologist
This is a cross-specialty problem and benefits from both perspectives:
For your prescriber:
- Report the acne with a specific timeline and dose correlation
- Ask about a dose reduction — less HPA axis activation, less adrenal androgen stimulation
- Consider whether a non-stimulant ADHD medication (atomoxetine, guanfacine) is clinically appropriate — some patients report clearing of stimulant-related acne upon switching
For your dermatologist:
- Request DHEA-S, androstenedione, free testosterone, and cortisol testing — these are the biomarkers most likely to be elevated if Vyvanse’s HPA axis stimulation is the driver
- Discuss hormonal acne treatments: in women, spironolactone (an anti-androgen) and combined oral contraceptive pills that contain anti-androgenic progestogens (e.g., cyproterone acetate) directly counteract the adrenal androgen mechanism and are highly effective for this pattern
- For severe cases: isotretinoin (Accutane) is the most definitive treatment for cystic acne; note that concurrent Vyvanse and isotretinoin use requires careful monitoring due to combined liver demands
- Topical treatments: tretinoin (vitamin A derivative), topical antibiotics, and azelaic acidall have specific utility for hormonal acne patterns
Safety and Important Considerations for Australian Adults
- Acne is not listed in the Australian TGA Consumer Medicine Information for Vyvanseas a standard side effect — this does not mean it doesn’t occur. It reflects the limits of pre-approval trial detection, not the full post-market side effect profile
- Report acne as a suspected adverse effect to the TGA at reports.tga.gov.au — patient-reported adverse events for unlisted side effects are a critical part of post-market safety surveillance and help build the evidence base for labelling updates
- In Australia, spironolactone is available and widely prescribed by dermatologists for adult female hormonal acne — it is an appropriate medication to discuss with your dermatologist if Vyvanse-related hormonal acne is your presentation, and does not require stopping Vyvanse to use
- Do not stop Vyvanse without prescriber guidance on the basis of skin concerns alone — there are management strategies available that may allow both effective ADHD treatment and resolution of the acne simultaneously
Common Misconceptions About Vyvanse and Acne
Myth 1: “Vyvanse doesn’t cause acne — it’s not in the side effect list.”The absence from the prescribing information reflects the pre-approval trial detection threshold, not the complete post-market side effect profile. Phase IV clinical data identifies acne as a reported adverse effect, peer-reviewed pharmacological research identifies a plausible and specific mechanism (adrenal androgen elevation), and consistent patient pharmacovigilance data shows clear dose-temporal correlations. Dismissing the association because it is unlisted is not clinically accurate.
Myth 2: “The acne is just hormones — it’s nothing to do with Vyvanse.”Vyvanse directly stimulates adrenal androgen secretion through HPA axis activation — which is a hormonal mechanism. Saying “it’s hormonal acne, not Vyvanse” misses the point: Vyvanse is the reason the hormonal shift is happening. Adult hormonal acne in women who were clear-skinned before starting Vyvanse, that resolves on medication holidays and returns on reinstatement, is highly likely to be Vyvanse-driven hormonal acne rather than coincidental hormonal acne.
Myth 3: “Drinking more water will solve Vyvanse acne.”Hydration addresses one of the four mechanisms — the dehydration-driven compensatory sebum production pathway — and is a valuable first intervention. But if the primary driver is adrenal androgen elevation producing genuine hormonal acne, hydration alone will not produce clinical clearance. Multi-mechanism management is required for the more androgen-driven presentations.
Myth 4: “Stopping Vyvanse will immediately clear the acne.”Resolution after stopping Vyvanse is not immediate — it typically takes 3–6 months for the hormonal environment to normalise and for active lesions to fully resolve. One patient documented this accurately: “After discontinuing Vyvanse within 1–2 weeks, I stopped seeing new breakouts, and my skin cleared completely after about four months off the medication”. Stopping the trigger stops new lesion formation; clearing existing lesions takes significantly longer.
Does Vyvanse cause acne Hobart
Does Vyvanse cause acne Devonport
Does Vyvanse cause acne Launceston
Does Vyvanse cause acne Tasmania
Does Vyvanse cause acne Victoria
Does Vyvanse cause acne Queensland
Does Vyvanse cause acne Canberra
Does Vyvanse cause acne Australian Capital Territory
Does Vyvanse cause acne South Australia
Does Vyvanse cause acne New South Wales
Does Vyvanse cause acne Darwin
Does Vyvanse cause acne Ghan
Does Vyvanse cause acne Northern Territory
Does Vyvanse cause acne Australia
Does Vyvanse cause acne Austria
Does Vyvanse cause acne Germany
Does Vyvanse cause acne United Kingdom
Does Vyvanse cause acne Sweden
Does Vyvanse cause acne Denmark
Does Vyvanse cause acne Norway
Does Vyvanse cause acne Finland
Does Vyvanse cause acne Iceland
Does Vyvanse cause acne Netherlands
Does Vyvanse cause acne Spain
Does Vyvanse cause acne Ireland
Does Vyvanse cause acne Switzerland
FAQ: People Also Ask About Vyvanse and Acne
Why does Vyvanse cause hormonal acne?Vyvanse stimulates the HPA axis, increasing adrenal androgens — specifically DHEA and androstenedione — which are converted in skin tissue to DHT, the primary driver of sebaceous gland activity and sebum production. Elevated sebum, combined with Vyvanse’s cortisol-driven inflammatory amplification and skin barrier disruption, creates the hormonal acne pattern concentrated along the jawline and chin. This is the most pharmacologically specific mechanism identified to date and is supported by both the controlled pharmacology study on lisdexamfetamine’s hormonal effects and the clinical literature on adrenal androgen-driven postadolescent acne.
Does Vyvanse cause cystic acne?Yes — cystic and nodular acne is the most commonly reported type in Vyvanse users who develop acne. This is consistent with the hormonal mechanism: DHT-driven sebaceous hyperactivity combined with cortisol-driven inflammation produces the deep, inflammatory lesion type rather than superficial comedonal acne. Cystic lesions are the most treatment-resistant and most scarring type, which makes early recognition and intervention important.
Does Vyvanse acne go away?If the cause is Vyvanse and the medication is discontinued or reduced, new lesion formation typically stops within 1–2 weeks. Full clearance of existing lesions takes 3–6 months in most cases. If the medication is continued, acne can be managed — sometimes successfully — through hormonal treatments (spironolactone, combined OCP), isotretinoin, and topical treatments, but may persist at some level as long as the androgenic stimulus continues.
Can I treat Vyvanse acne without stopping the medication?Yes — particularly for women, hormonal treatments that directly counter the adrenal androgen mechanism are effective alongside continued Vyvanse use. Spironolactone (50–200 mg/day) blocks androgen receptors in the skin and significantly reduces sebum production driven by adrenal androgens. Combined oral contraceptive pills with anti-androgenic progestogens reduce adrenal androgen activity through HPG axis feedback. Isotretinoin is the most definitive option for severe cystic acne regardless of cause. A dermatologist consultation is the appropriate step for this management pathway.
Does Vyvanse cause acne in men?Less commonly — the adrenal androgen pathway that drives the most pharmacologically specific Vyvanse-acne mechanism is most clinically significant in women because of women’s greater skin sensitivity to adrenal androgen changes relative to baseline. Men’s skin is already exposed to higher baseline androgen levels; the incremental DHEA elevation from Vyvanse produces a relatively smaller proportional shift. Male patients on Vyvanse can still experience acne via the cortisol and dehydration mechanisms, but the severe cystic hormonal acne pattern concentrated at the jawline is predominantly a female presentation.
Why does my Vyvanse acne appear on my jawline?The jawline is the anatomical distribution characteristic of androgen-driven hormonal acne. This region has the highest density of sebaceous glands that are most responsive to DHT-driven stimulation — the precise biomarker elevated by Vyvanse’s adrenal androgen mechanism. Jawline acne from hormonal drivers behaves differently from facial acne in other zones: it tends to be deeper, more inflammatory, more cystic, and less responsive to topical treatments alone. Recognising the jawline distribution as a hormonal signal directs treatment toward anti-androgen approaches rather than topical acne treatment alone.
